Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 5037 | 1615 | 31.9 | 41% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PRACTICE POINTS | Author keyword | 1 | 100% | 0% | 2 |
| 2 | RENAL PROSTANOIDS | Author keyword | 1 | 50% | 0% | 2 |
| 3 | PAH CLEARANCE | Author keyword | 1 | 40% | 0% | 2 |
| 4 | 11 SEIRYO MACHIAOBA KU | Address | 1 | 50% | 0% | 1 |
| 5 | 6 KETO PROSTAGLANDIN F 1 | Author keyword | 1 | 50% | 0% | 1 |
| 6 | BRADYKININ POTENTIATING PEPTIDE BPP | Author keyword | 1 | 50% | 0% | 1 |
| 7 | C 14 LINOLEIC ACID | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CAS 27589 33 9 | Author keyword | 1 | 50% | 0% | 1 |
| 9 | COX ISOFORMS | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ESTRADIOL DROSPIRENONE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PRACTICE POINTS | 1 | 100% | 0% | 2 | Search PRACTICE+POINTS | Search PRACTICE+POINTS |
| 2 | RENAL PROSTANOIDS | 1 | 50% | 0% | 2 | Search RENAL+PROSTANOIDS | Search RENAL+PROSTANOIDS |
| 3 | PAH CLEARANCE | 1 | 40% | 0% | 2 | Search PAH+CLEARANCE | Search PAH+CLEARANCE |
| 4 | 6 KETO PROSTAGLANDIN F 1 | 1 | 50% | 0% | 1 | Search 6+KETO+PROSTAGLANDIN+F+1 | Search 6+KETO+PROSTAGLANDIN+F+1 |
| 5 | BRADYKININ POTENTIATING PEPTIDE BPP | 1 | 50% | 0% | 1 | Search BRADYKININ+POTENTIATING+PEPTIDE+BPP | Search BRADYKININ+POTENTIATING+PEPTIDE+BPP |
| 6 | C 14 LINOLEIC ACID | 1 | 50% | 0% | 1 | Search C+14+LINOLEIC+ACID | Search C+14+LINOLEIC+ACID |
| 7 | CAS 27589 33 9 | 1 | 50% | 0% | 1 | Search CAS+27589+33+9 | Search CAS+27589+33+9 |
| 8 | COX ISOFORMS | 1 | 50% | 0% | 1 | Search COX+ISOFORMS | Search COX+ISOFORMS |
| 9 | ESTRADIOL DROSPIRENONE | 1 | 50% | 0% | 1 | Search ESTRADIOL+DROSPIRENONE | Search ESTRADIOL+DROSPIRENONE |
| 10 | EXCHANGEABLE BODY SODIUM | 1 | 50% | 0% | 1 | Search EXCHANGEABLE+BODY+SODIUM | Search EXCHANGEABLE+BODY+SODIUM |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RENAL PROSTAGLANDIN SYNTHESIS | 11 | 78% | 0% | 7 |
| 2 | CHRONIC GLOMERULAR DISEASE | 8 | 75% | 0% | 6 |
| 3 | FENOPROFEN NEPHROPATHY | 7 | 67% | 0% | 6 |
| 4 | PROSTAGLANDIN EXCRETION | 6 | 80% | 0% | 4 |
| 5 | URINARY PROSTAGLANDIN E2 | 4 | 75% | 0% | 3 |
| 6 | ASPIRIN INDUCED DEPRESSION | 3 | 100% | 0% | 3 |
| 7 | ANTIHYPERTENSIVE ACTION | 2 | 23% | 0% | 7 |
| 8 | URINARY PROSTANOID EXCRETION | 1 | 100% | 0% | 2 |
| 9 | PROSTAGLANDIN INHIBITION | 1 | 33% | 0% | 3 |
| 10 | PAPILLARY NECROSIS | 1 | 10% | 0% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| NONSTEROIDAL ANTIINFLAMMATORY DRUGS - EFFECTS ON KIDNEY-FUNCTION | 1991 | 170 | 30 | 90% |
| RENAL SYNDROMES ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS | 1984 | 938 | 42 | 83% |
| THE CLINICAL-SIGNIFICANCE OF INHIBITION OF RENAL PROSTAGLANDIN SYNTHESIS | 1987 | 212 | 72 | 72% |
| NSAIDs and increased blood pressure - What is the clinical significance? | 1997 | 66 | 83 | 72% |
| EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON PROSTAGLANDINS AND RENAL-FUNCTION | 1985 | 192 | 36 | 83% |
| RENAL COMPLICATIONS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS | 1993 | 179 | 91 | 53% |
| CLINICAL IMPLICATIONS OF PROSTAGLANDIN AND THROMBOXANE A-2 FORMATION .2. | 1988 | 181 | 47 | 38% |
| The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk | 1998 | 39 | 21 | 48% |
| Renal complications associated with use of nonsteroidal anti-inflammatory agents | 1995 | 61 | 130 | 55% |
| Clinical pharmacokinetics of sulindac - A dynamic old drug | 1997 | 46 | 114 | 49% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 11 SEIRYO MACHIAOBA KU | 1 | 50% | 0.1% | 1 |
| 2 | IRCCSDIPARTIMENTO MED INTERNA | 1 | 50% | 0.1% | 1 |
| 3 | MED CNR STUDIO FISIOPATOL SHOCK | 1 | 50% | 0.1% | 1 |
| 4 | MED DENT OOL | 1 | 50% | 0.1% | 1 |
| 5 | PLA GEN STAFF | 1 | 50% | 0.1% | 1 |
| 6 | PRINCE HENRYS HOSP MED | 1 | 50% | 0.1% | 1 |
| 7 | CAROLINA VASC BIOL | 0 | 33% | 0.1% | 1 |
| 8 | CHILDRENS HOSP NEONATOL | 0 | 33% | 0.1% | 1 |
| 9 | GARDEN CITY HOSP | 0 | 33% | 0.1% | 1 |
| 10 | GRP INVEST PROMOC PREVENC FARMACEUT | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000192580 | GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//SERV 151 E |
| 2 | 0.0000128435 | ANALGESIC NEPHROPATHY//RENAL PAPILLARY NECROSIS//ANALGESIC ASSOCIATED NEPHROPATHY |
| 3 | 0.0000128375 | MED BIOCHEM KURAMOTO CHO//4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE//PHARMACEUT S KITA KU |
| 4 | 0.0000108578 | AGGREGATED PROTEIN//IMMUNOGLOBULIN G COMPLEXES//MESANGIUM |
| 5 | 0.0000098933 | PATHOLCARDIOVASC//RENAL PROSTANOIDS//MCGUIRE |
| 6 | 0.0000096956 | CICLETANINE//CA 2 ACTIVATED POTASSIUM CHANNEL//ELECTROTONIC PROPAGATION |
| 7 | 0.0000088638 | OXAPROZIN//BRYONIA LACINIOSA//TIAPROFENIC ACID |
| 8 | 0.0000082792 | DRUG INDUCED ASEPTIC MENINGITIS//IBUPROFEN TOXICITY//MED PHARM CLIN PHARM |
| 9 | 0.0000081342 | PREVU POC SKIN STEROL TEST//SKIN TISSUE CHOLESTEROL//ATHEROSCLEROSIS REVERSAL CLIN |
| 10 | 0.0000080440 | TINU SYNDROME//ACUTE INTERSTITIAL NEPHRITIS//TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME |